---
title: "Takeda faces $885m hit after landmark pay-for-delay lawsuit verdict"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287084055.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-05-20T10:15:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287084055.md)
  - [en](https://longbridge.com/en/news/287084055.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287084055.md)
---

# Takeda faces $885m hit after landmark pay-for-delay lawsuit verdict

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [TAK.US](https://longbridge.com/en/quote/TAK.US.md)
- [4502.JP](https://longbridge.com/en/quote/4502.JP.md)

## Related News & Research

- [Takeda Pharmaceutical - Currently Assessing Amount Of Provision To Be Recognized In Group Earnings For FY Ended March 31](https://longbridge.com/en/news/286837374.md)
- [Takeda Pharmaceutical (NYSE:TAK) Posts Quarterly Earnings Results, Beats Expectations By $0.36 EPS](https://longbridge.com/en/news/286621568.md)
- [US jury to decide if Takeda delayed generic constipation drug](https://longbridge.com/en/news/286455075.md)
- [Takeda Ordered To Pay $884.9 Mln In AMITIZA Antitrust Case; To Revise FY25 Results](https://longbridge.com/en/news/286858624.md)
- [Takeda faces major AMITIZA antitrust verdict and prepares FY2025 provision](https://longbridge.com/en/news/286840681.md)